Edition:
India

Koninklijke DSM NV (DSMN.AS)

DSMN.AS on Amsterdam Stock Exchange

80.45EUR
3:02pm IST
Change (% chg)

€-0.39 (-0.48%)
Prev Close
€80.84
Open
€80.80
Day's High
€81.13
Day's Low
€80.35
Volume
90,786
Avg. Vol
682,004
52-wk High
€81.17
52-wk Low
€54.82

Latest Key Developments (Source: Significant Developments)

DSM To Expand Capacity Of High Performance Plastics‍​
Monday, 27 Nov 2017 

Nov 27 (Reuters) - DSM ::DSM TO EXPAND CAPACITY OF HIGH PERFORMANCE PLASTICS‍​.RESPONDING TO STRONG CUSTOMER DEMAND IN HIGH TEMPERATURE POLYAMIDES AND THERMOPLASTIC COPOLYESTERS.IN PROCESS OF BRINGING 25% ADDITIONAL ARNITEL CAPACITY ONLINE IN 2018‍​.IN PROCESS OF EXPANDING CAPACITY OF ITS SPECIALTY POLYMERS PLANTS IN EMMEN AND GELEEN, THE NETHERLANDS.  Full Article

Koninklijke DSM invests 15 million euros to expand capacity of plant in Meppen, Germany
Thursday, 23 Nov 2017 

Nov 23 (Reuters) - KONINKLIJKE DSM NV : :KONINKLIJKE DSM NV - DSM INVESTS €15 MILLION TO EXPAND CAPACITY AT COATING RESINS PLANT IN MEPPEN (GERMANY).FACILITY IS SPECIALIZED IN THE PRODUCTION OF LIQUID POLYESTERS AND OTHER SPECIALTY RESINS‍​.  Full Article

DSM acquires Brazilian production facility from Amyris
Friday, 17 Nov 2017 

Nov 17 (Reuters) - Amyris Inc :DSM expands strategic alliance with Amyris and acquires Brazilian production facility from Amyris.Royal DSM - consideration for Amyris Brasil, intellectual property related to farnesene, value share arrangement over 3-year period amounts to $96 million​.‍Royal DSM says in addition to consideration upfront there is potential for a future value share in line with Amyris' business model​.  Full Article

DSM signs technology partnership agreement with Toyota Motorsport GmbH‍​
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - DSM ::SIGNS TECHNOLOGY PARTNERSHIP AGREEMENT WITH TOYOTA MOTORSPORT GMBH‍​.AGREEMENT INVOLVES ALL DSM BUSINESSES ACTIVE IN SUPPLYING MATERIALS AND TECHNOLOGY TO THE AUTOMOTIVE SECTOR.  Full Article

DSM announces ‍9-month sales at 6.47 billion, up 9%
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - DSM ::‍9M SALES UP 9% TO EUR 6,456M, WITH 8% ORGANIC GROWTH​.‍9M ADJUSTED EBITDA UP 15% TO EUR 1,086M​.‍9M ADJUSTED NET PROFIT UP 29% TO EUR 504M​.‍9M ROCE UP 170 BPS TO 12.3%​.‍OUTLOOK 2017 UNCHANGED​.‍9M TOTAL NET PROFIT OF EUR 1,603M​.  Full Article

DSM announces price increases for its Akulon portfolio in Europe
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - DSM NV ::ANNOUNCES PRICE INCREASES FOR ITS AKULON PORTFOLIO IN EUROPE.DUE TO RISING FEEDSTOCKS AND STRONG GLOBAL DEMANDS, INCREASES PRICE FOR ITS POLYAMIDE 6 & 66 COMPOUND PORTFOLIO BY 300 €/T.INCREASES TO TAKE EFFECT FOR ALL ORDERS SHIPPED ON OR AFTER NOV. 1 OR FOLLOW AS CONTRACTS ALLOW.CONTINUES TO PURSUE AND IMPLEMENT COST SAVINGS TARGETED AT STABILIZING THE IMPACT OF RAW MATERIALS.  Full Article

Dsm ‍announces partnership with Cerapedics​
Thursday, 12 Oct 2017 

Oct 12 (Reuters) - DSM ::‍ANNOUNCES PARTNERSHIP WITH CERAPEDICS​.  Full Article

DSM announces Somos distribution agreement with RP America​
Tuesday, 10 Oct 2017 

Oct 10 (Reuters) - KONINKLIJKE DSM NV ::‍DSM ANNOUNCES SOMOS® DISTRIBUTION AGREEMENT WITH RP AMERICA​.  Full Article

DSM sees 2017 CAPEX to be between 500 and 550 million euros - conf call
Wednesday, 15 Feb 2017 

DSM : Sees 2017 CAPEX to be between 500 million euros ($528 million) and 550 million euros - conference call . Says prices in the beginning of 2017 expected to be approximately equivalent to prices in the beginning of 2016 - conference call . Says expecting continued growth for 2017 including in the animal nutrition business - conference call . Says focusing on operational performance for 2016/2017 - conference call . Says does not anticipate higher prices at this moment - conference call . Says market conditions remain pretty solid - conference call . Expects to grow on nutrition business of about 3 to 4 percent for 2017 - conference call . Says bird flu situation expected to have no major impact on their business - conference call Further company coverage: [DSMN.AS] ($1 = 0.9474 euros) (Gdynia Newsroom) ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;)).  Full Article

DSM FY net profit up at 629 million euros
Wednesday, 15 Feb 2017 

DSM : FY revenue 7.92 billion euros ($8.38 billion) versus 7.72 billion euros year ago . FY Sales up 3 pct to 7,920 million euros, with 4 pct organic growth . FY adjusted EBITDA up 17 pct to 1,262 million euros . FY net profit of 629 million euros compared to 92 million in 2015 . Proposed dividend increase from 1.65 euros to 1.75 euros per ordinary share . DSM aims to deliver high single-digit percentage adjusted EBITDA growth and high double-digit basis point roce growth in line with targets set out in its strategy 2018 . Q4 revenue 2.01 billion euros versus 1.99 billion euros in Reuters Poll . Q4 nutrition sales 1.32 billion euros versus 1.32 billion euros in Reuters Poll . Q4 Adjusted EBITDA 315 million euros versus 311 million euros in Reuters Poll .Q4 adjusted net profit from continuing operations 130 million euros versus 132 million euros in Reuters Poll.  Full Article

BRIEF-DSM acquires Brazilian production facility from Amyris

* DSM expands strategic alliance with Amyris and acquires Brazilian production facility from Amyris